Inflammatory bowel disease treatment in the time of COVID: Patient perceptions and decision-making (Cindy Kin, Sarah Streett)

Kin and Streett are exploring how people with inflammatory bowel diseases, including people with Crohn’s disease and ulcerative colitis whose treatment frequently involves chronic immunosuppressive therapies, are affected by the COVID-19 outbreak. The study aims to understand the primary concerns that patients with inflammatory bowel diseases have about their illnesses and treatments as they relate to the COVID-19 epidemic so that physicians and the health care team can effectively engage them in shared decision-making. Stanford Office of Technology Licensing info@otlmail.stanford.edu. 650-723-0651